Description
Anti-TNFRSF12 (Enavatuzumab) -MC-Vc-PAB-SN38 ADC | ADC-W-1902 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an anti-TNFRSF12 monoclonal antibody conjugated via a MC-Vc-PAB linker to SN38
Status: In stock
Expected Delivery Time: 9-11Weeks